How much funding has Molecular Stethoscope raised?

Molecular Stethoscope has raised $8.2M in total funding, most recently a Series A round.

Who are Molecular Stethoscope's investors?

Molecular Stethoscope's investors include DCVC (Data Collab), Pfizer Ventures, Index Ventures.

When was Molecular Stethoscope founded?

Molecular Stethoscope was founded in 2014.

Where is Molecular Stethoscope headquartered?

Molecular Stethoscope is headquartered in South San Francisco, California, United States.

What industry is Molecular Stethoscope in?

Molecular Stethoscope operates in Biotech, Healthcare.

Molecular Stethoscope

South San Francisco, United States · Founded 2014 · $8.2M raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Founded: 2014
Business Model: B2B

Total Funding: $8.2M
Last Round: $8.2M Series ADec 2023
Rounds: 2

About

Molecular Stethoscope was a South San Francisco-based molecular diagnostics company that developed liquid biopsy tests using cell-free RNA to assess tissue and organ health non-invasively. Founded in 2014, the company pioneered cfRNA profiling approaches applicable to cancer detection and organ monitoring. The company later evolved into Superfluid Diagnostics (Superfluid Dx), continuing its liquid biopsy work.

Summary

Molecular Stethoscope is a Biotech company based in South San Francisco, United States, founded in 2014. It has raised $8.2M in total across 2 rounds, most recently a $8.2M Series A round in Dec 2023. Investors include DCVC (Data Collab), Pfizer Ventures and Index Ventures.